INSIGHTS ON DRUG DEVELOPMENT

• Walk-Away Monitoring Of Cytotoxicity, Viability, And Apoptosis

  Real-time cell health monitoring reveals how drug dose and timing impact apoptosis, necrosis, and viability. Explore how automated workflows help pinpoint mechanistic toxicity windows.

• Expanding Translational Research Concepts With Genedata Profiler

  The biopharma industry leverages Genedata Profiler to integrate, curate, and analyze diverse R&D data, enabling collaborative, compliant, and AI-driven translational research to optimize drug development.

• Using Residual DNA Quantification Data To De-Risk mAb Development

  Residual DNA quantitation offers more than impurity measurement. When used across process steps, it helps compare purification performance, identify risks early, and ensure assays remain reliable.

• SEC HPLC Columns With Ultra Inert Technology

  See how reducing secondary interactions in size exclusion chromatography gives scientists greater freedom to optimize conditions around their samples, helping simplify method development.

• ADC Development Grows More Complex — SPR Insights Bring Clarity

  4/14/2026

  Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.

• Shining A Light On Dark Data

  6/11/2026

  Centralizing data unlocks faster insights, reduces duplicated effort, and improves compliance. By overcoming silos and “dark data,” organizations can enable efficient search, reuse, and analysis.

• Real-Time Growth Monitoring Of Spheroids In Round Bottom Microplates

  11/7/2025

  Real-time spheroid monitoring combines brightfield and fluorescence imaging with automated analysis. Find out how this workflow enhances reproducibility and supports high-content 3D cell culture applications.

• Navigating Complexity: Tailored Analytical & Preclinical Services

  2/26/2026

  Tailored analytical and preclinical strategies identify risk early, integrate data-driven insight, and streamline formulation planning to accelerate timelines and position complex molecules for scalable, successful development.

• Quicker Development Using Cell Line Integration, End-To-End Support

  6/19/2025

  Despite challenges with mammalian host cell line diversity, Lonza's mitigation strategies drive efficiency and reproducibility, maximizing cell growth and product quality.